The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2

por Ryu, Dong-Kyun, Kang, Bobin, Noh, Hanmi, Woo, Sun-Je, Lee, Min-Ho, Nuijten, Patricia M., Kim, Jong-In, Seo, Ji-Min, Kim, Cheolmin, Kim, Minsoo, Yang, Eunji, Lim, Gippeum, Kim, Seong-Gyu, Eo, Su-Kyeong, Choi, Jung-ah, Song, Manki, Oh, Sang-Seok, Chung, Hyo-Young, Tijsma, Aloys SL., van Baalen, Carel A., Kwon, Ki-Sung, Lee, Soo-Young
Publicado 2021

Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

por Seo, Ji-Min, Kang, Bobin, Song, Rina, Noh, Hanmi, Kim, Cheolmin, Kim, Jong-In, Kim, Minsoo, Ryu, Dong-Kyun, Lee, Min-Ho, Yang, Jeong-Sun, Kim, Kyung-Chang, Lee, Joo-Yeon, Lee, Hansaem, Woo, Hye-Min, Kim, Jun-Won, Choi, Jung-Ah, Song, Manki, Tomaszewska-Kiecana, Monika, Wołowik, Anna, Kulesza, Agnieszka, Kim, Sunghyun, Ahn, Keumyoung, Jung, Nahyun, Lee, Soo-Young
Publicado 2022